NY A09651

Establishes a maternal health monitoring pilot program within the New York Department of Health to provide remote patient monitoring for maternal hypertension and diabetes during pregnancy and up to three months postpartum

Targets Medicaid recipients who are pregnant and enrolled in participating managed care organizations, with implementation in up to 500 participants across counties including designated maternity care deserts

Requires technology vendors to provide FDA-authorized monitoring devices that track blood pressure, weight, and blood glucose, with data transmitted via cellular networks and reviewed by licensed clinical care teams

Allocates $600,000 to offset program costs, with the pilot running for two years after becoming operational (no later than 180 days after contract signing)

Mandates a report within two years evaluating maternal outcomes (mortality, morbidity, preeclampsia, C-section rates) and fetal/neonatal outcomes (mortality, NICU admissions, preterm birth rates) with recommendations on statewide expansion